BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 15574551)

  • 1. Aprotinin decreases the incidence of cognitive deficit following CABG and cardiopulmonary bypass: a pilot randomized controlled study.
    Harmon DC; Ghori KG; Eustace NP; O'Callaghan SJ; O'Donnell AP; Shorten GD
    Can J Anaesth; 2004 Dec; 51(10):1002-9. PubMed ID: 15574551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative delirium and short-term cognitive dysfunction occur more frequently in patients undergoing valve surgery with or without coronary artery bypass graft surgery compared with coronary artery bypass graft surgery alone: results of a pilot study.
    Hudetz JA; Iqbal Z; Gandhi SD; Patterson KM; Byrne AJ; Pagel PS
    J Cardiothorac Vasc Anesth; 2011 Oct; 25(5):811-6. PubMed ID: 20655248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
    Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
    Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery bypass grafting with single cross-clamp results in fewer persistent neuropsychological deficits than multiple clamp or off-pump coronary artery bypass grafting.
    Hammon JW; Stump DA; Butterworth JF; Moody DM; Rorie K; Deal DD; Kincaid EH; Oaks TE; Kon ND
    Ann Thorac Surg; 2007 Oct; 84(4):1174-8; discussion 1178-9. PubMed ID: 17888966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full-dose aprotinin use in coronary artery bypass graft surgery: an analysis of perioperative pharmacotherapy and patient outcomes.
    Royston D; Levy JH; Fitch J; Dietrich W; Body SC; Murkin JM; Spiess BD; Nadel A
    Anesth Analg; 2006 Nov; 103(5):1082-8. PubMed ID: 17056936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive outcomes in elderly high-risk patients 1 year after off-pump versus on-pump coronary artery bypass grafting. A randomized trial.
    Jensen BØ; Rasmussen LS; Steinbrüchel DA
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1016-21. PubMed ID: 18778948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative neuropsychological change and its underlying mechanism in patients undergoing coronary artery bypass grafting.
    Yin YQ; Luo AL; Guo XY; Li LH; Huang YG
    Chin Med J (Engl); 2007 Nov; 120(22):1951-7. PubMed ID: 18067777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose aprotinin modulates the balance between proinflammatory and anti-inflammatory responses during coronary artery bypass graft surgery.
    Tassani P; Augustin N; Barankay A; Braun SL; Zaccaria F; Richter JA
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):682-6. PubMed ID: 11139109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of coronary artery bypass graft surgery on health-related quality of life, cognitive performance, and emotional status outcomes: a prospective 6-month follow-up consultation-liaison psychiatry study].
    Rothenhäusler HB; Stepan A; Hetterle R; Trantina-Yates A
    Fortschr Neurol Psychiatr; 2010 Jun; 78(6):343-54. PubMed ID: 20336599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrifugal versus roller head pumps for cardiopulmonary bypass: effect on early neuropsychologic outcomes after coronary artery surgery.
    Scott DA; Silbert BS; Doyle TJ; Blyth C; Borton MC; O'brien JL; de L Horne DJ
    J Cardiothorac Vasc Anesth; 2002 Dec; 16(6):715-22. PubMed ID: 12486652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
    van der Linden J; Lindvall G; Sartipy U
    Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting.
    Lindvall G; Sartipy U; van der Linden J
    Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beating heart versus conventional cardiopulmonary bypass: the octopus experience: a randomized comparison of 281 patients undergoing coronary artery bypass surgery with or without cardiopulmonary bypass.
    van Dijk D; Diephuis JC; Nierich AP; Keizer AM; Kalkman CJ
    Semin Cardiothorac Vasc Anesth; 2006 Jun; 10(2):167-70. PubMed ID: 16959744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial.
    Jensen BO; Hughes P; Rasmussen LS; Pedersen PU; Steinbrüchel DA
    Circulation; 2006 Jun; 113(24):2790-5. PubMed ID: 16769915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative cognitive dysfunction is independent of type of surgery and anesthetic.
    Evered L; Scott DA; Silbert B; Maruff P
    Anesth Analg; 2011 May; 112(5):1179-85. PubMed ID: 21474666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piracetam prevents cognitive decline in coronary artery bypass: a randomized trial versus placebo.
    Szalma I; Kiss A; Kardos L; Horváth G; Nyitrai E; Tordai Z; Csiba L
    Ann Thorac Surg; 2006 Oct; 82(4):1430-5. PubMed ID: 16996947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study.
    Øvrum E; Tangen G; Tølløfsrud S; Ringdal MA; Øystese R; Istad R
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):545-8. PubMed ID: 20067988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychologic and quality-of-life outcomes after coronary artery bypass surgery with and without cardiopulmonary bypass: a prospective randomized trial.
    Tully PJ; Baker RA; Kneebone AC; Knight JL
    J Cardiothorac Vasc Anesth; 2008 Aug; 22(4):515-21. PubMed ID: 18662624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.